Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04529889 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GDM and Its Consequences in Mothers and Offsprings

Study acronym: GDMCMO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Mar 21, 2022, no change to tracked fieldsv3-v4
  2. Primary completion date: Dec 31, 2020 to Dec 31, 2038v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Gestational diabetes mellitus (GDM) is one of the most common disorders which occured during pregnancy. GDM is not only associated with short-term maternal and fetal adverse outcomes, but also related to a wide range of long-term consequences for both mother and child. The GDM and Its Consequences for mothers and offsprings (GDMCMO) aims to establish a cohort to follow both maternal and offsprings'short-term and long-term outcomes, including fetal malformations including congenital heart diseases, birth weight, preterm birth, caesarean section delivery, body growth and neurodevelopment after birth, obesity, type 2 diabetes and impaired insulin sensitivity and secretion, lung health and allergic diseases later in life for offspring, as well as future type 2 diabetes and cardiovascular risk factors for mother after delivery. Biological samples including blood and tissue samples of mothers and children are also collected during pregnancy and after delivery.
Trial Details
NCT Number NCT04529889
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions
(from sponsor)		 Gestational Diabetes Mellitus, Pregnancy Outcome, Neurodevelopment, Immune Development, Childhood Obesity, Host and Microbiome
Related terms Diabetes, Gestational, Hyperglycemia, Pediatric Obesity
Enrollment 7,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov